NCCN 22nd Annual Conference

NCCN 22nd Annual Conference
The NCCN 22nd Annual Conference: Improving the Quality, Effectiveness, and Efficiency of Cancer Care, held March 23-25, 2017, brings together oncology physicians, nurses, pharmacists, and other professionals involved in oncology care. The meeting provides attendees an update on new therapies, NCCN Guidelines, and quality initiatives in oncology. Sign up for our daily e-mail blasts on our registration page, and check back here during the conference for the full coverage.
June 06, 2017
The large database of information contained in the California Cancer Registry is useful for both local clinicians and researchers around the world, as it allows them to compare cancer outcomes by a number of demographic characteristics, according to Moon S. Chen Jr, PhD, MPH, professor of hematology and oncology at UC Davis Comprehensive Cancer Center and principal investigator of The National Center for Reducing Asian American Cancer Health Disparities.
May 20, 2017
Matthew Gubens, MD, MS, assistant clinical professor of thoracic oncology at the University of California, San Francisco, discussed the areas of lung immuno-oncology research where he anticipates significant advances will be made in coming years.
May 13, 2017
When developing interventions to improve population health, particularly among minority groups, research must take a culturally sensitive approach that is targeted to the specific needs of that population, according to Moon S. Chen Jr, PhD, MPH, professor of hematology and oncology at UC Davis Comprehensive Cancer Center and principal investigator of The National Center for Reducing Asian American Cancer Health Disparities. He also emphasized the importance of clinicians’ role in population health.
April 28, 2017
Programs like One Great Community aim to engage communities in the process of population health research, which is a key to successful public health initiatives, explained Shauntice Allen, PhD, assistant professor in the University of Alabama at Birmingham School of Public Health.
April 24, 2017
By understanding the biology of myeloma tumor cells, researchers can better develop therapies, including drug combinations, that target the complex mechanisms at play in the disease, according to Shaji Kumar, MD, professor of medicine at the Mayo Clinic.
April 21, 2017
When employing immunotherapies, oncologists must be vigilant in spotting any adverse events and calling in their colleagues, like dermatologists or pulmonologists, to help manage these toxicities, according to Matthew Gubens, MD, MS, assistant clinical professor of thoracic oncology at the University of California, San Francisco.
April 16, 2017
Two of the most important determinants of cancer outcomes are the culture and behavior of both the provider and the patient, explained Moon S. Chen Jr, PhD, MPH, professor of hematology and oncology at UC Davis Comprehensive Cancer Center and principal investigator of The National Center for Reducing Asian American Cancer Health Disparities.
March 26, 2017
At the 22nd Annual Conference of the National Comprehensive Cancer Network, in Orlando, Florida, Paul M. Cinciripini, PhD, of the University of Texas MD Anderson Cancer Center delivered a presentation on a mission he said he has spent the better part of his life working on: getting patients with cancer to quit smoking cigarettes.
March 25, 2017
Until the underlying community health factors like poverty and education are addressed, disparities in cancer outcomes will persist, according to Shauntice Allen, PhD, assistant professor in the University of Alabama at Birmingham School of Public Health. She also discussed how health systems and providers can contribute to efforts to improve community health.
March 25, 2017
Despite the abundance of new drugs that have been approved recently and the promising clinical trials of other novel therapies, multiple myeloma remains incurable, explained Shaji Kumar, MD, professor of medicine at the Mayo Clinic. However, he believes that with better options for early intervention and personalized therapies, researchers are on a path to curing the disease.
Copyright AJMC 2006-2017 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up
×

Sign In

Not a member? Sign up now!